Deciphering the Impact of

HER2 amplification lung cancer molecular pathology monoclonal antibody mutations next-generation sequencing non-small-cell lung cancer targeted therapies tyrosine kinase inhibitor

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
04 Oct 2022
Historique:
received: 18 08 2022
revised: 26 09 2022
accepted: 29 09 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

Despite the recent increase in the number of types of treatments, non-small-cell lung cancer (NSCLC) remains the major cause of death from cancer worldwide. So, there is an urgent need to develop new therapeutic strategies. The

Identifiants

pubmed: 36294789
pii: jpm12101651
doi: 10.3390/jpm12101651
pmc: PMC9605102
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Ann Oncol. 2019 Apr 1;30(4):597-603
pubmed: 30891595
J Clin Oncol. 2022 Mar 1;40(7):710-718
pubmed: 34843401
J Clin Oncol. 2022 Mar 1;40(7):702-709
pubmed: 34550757
Lancet. 2010 Aug 28;376(9742):687-97
pubmed: 20728210
Front Oncol. 2015 Jan 28;5:2
pubmed: 25674538
Cancer. 2017 Nov 1;123(21):4099-4105
pubmed: 28743157
Clin Cancer Res. 2012 Sep 15;18(18):4910-8
pubmed: 22761469
N Engl J Med. 2005 Jul 14;353(2):123-32
pubmed: 16014882
Cancer Immunol Immunother. 2022 Jul;71(7):1625-1631
pubmed: 34743223
Ann Oncol. 2019 Aug 1;30(8):1321-1328
pubmed: 31125062
Lung Cancer. 2018 Dec;126:72-79
pubmed: 30527195
J Clin Oncol. 2013 Jun 1;31(16):1997-2003
pubmed: 23610105
Cancer Cell. 2018 Nov 12;34(5):792-806.e5
pubmed: 30449325
Histopathology. 2006 Aug;49(2):161-9
pubmed: 16879393
Eur J Cancer. 2022 Feb;162:99-106
pubmed: 34959152
Cancer Discov. 2020 May;10(5):688-701
pubmed: 32213540
J Thorac Oncol. 2019 Jun;14(6):1086-1094
pubmed: 30825613
J Natl Compr Canc Netw. 2021 Mar 02;19(3):254-266
pubmed: 33668021
Cell. 2018 Apr 5;173(2):371-385.e18
pubmed: 29625053
Cancer Discov. 2021 Jul;11(7):1688-1699
pubmed: 33632775
Oncogene. 2007 Oct 4;26(45):6469-87
pubmed: 17471238
J Thorac Oncol. 2016 Mar;11(3):414-9
pubmed: 26723242
J Hematol Oncol. 2021 Jul 8;14(1):108
pubmed: 34238332
J Thorac Oncol. 2020 Apr;15(4):628-636
pubmed: 31945494
Cancer Res Treat. 2018 Jul;50(3):835-842
pubmed: 28859471
Front Oncol. 2013 Apr 23;3:86
pubmed: 23630663
Clin Cancer Res. 2001 Oct;7(10):3239-50
pubmed: 11595720
Nature. 2003 Feb 13;421(6924):756-60
pubmed: 12610629
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Cancer Sci. 2016 Jul;107(7):1039-46
pubmed: 27166974
J Mol Diagn. 2015 Sep;17(5):487-95
pubmed: 26320869
Clin Cancer Res. 2021 Mar 1;27(5):1463-1475
pubmed: 33355298
Clin Cancer Res. 2016 Oct 15;22(20):5097-5108
pubmed: 27026201
Cancers (Basel). 2022 Mar 23;14(7):
pubmed: 35406400
Oncologist. 2020 Mar;25(3):e545-e554
pubmed: 32162827
Cancer Res Treat. 2020 Jan;52(1):292-300
pubmed: 31345011
Cancer Cell. 2019 Oct 14;36(4):444-457.e7
pubmed: 31588020
Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14476-81
pubmed: 22908275
Int J Cancer. 2006 Dec 1;119(11):2586-91
pubmed: 16988931
PLoS One. 2017 Feb 1;12(2):e0171280
pubmed: 28146588
Thorac Cancer. 2020 Jun;11(6):1512-1521
pubmed: 32291971
Am Soc Clin Oncol Educ Book. 2020 May;40:372-384
pubmed: 32421452
Mod Pathol. 2013 Dec;26(12):1605-12
pubmed: 23765245
J Thorac Oncol. 2020 Jun;15(6):962-972
pubmed: 32036069
Cell Oncol. 2010;32(1-2):57-65
pubmed: 20208134
J Clin Oncol. 2018 Jul 10;36(20):2105-2122
pubmed: 29846122
Cancer Res. 2021 Oct 15;81(20):5311-5324
pubmed: 34380634
Clin Cancer Res. 2015 Aug 15;21(16):3631-9
pubmed: 25567908
Eur J Cancer. 2021 May;149:235-248
pubmed: 33820681
Clin Cancer Res. 2003 Nov 1;9(14):5238-43
pubmed: 14614004
N Engl J Med. 2022 Jan 20;386(3):241-251
pubmed: 34534430
Nat Med. 2018 May;24(5):638-646
pubmed: 29686424
Clin Cancer Res. 2018 Jun 1;24(11):2594-2604
pubmed: 29298799
Cancer Discov. 2020 May;10(5):674-687
pubmed: 32213539
Cancer Res. 2008 Nov 15;68(22):9280-90
pubmed: 19010901
Clin Cancer Res. 2019 Jan 1;25(1):64-72
pubmed: 30206164
J Clin Oncol. 2018 Jul 10;36(20):2044-2051
pubmed: 29584549
Onco Targets Ther. 2016 May 05;9:2709-16
pubmed: 27217781
Ann Oncol. 2019 Mar 1;30(3):447-455
pubmed: 30596880
Chest. 2019 Aug;156(2):357-366
pubmed: 31072612
Dis Markers. 2022 Aug 13;2022:8426384
pubmed: 35996715
World J Clin Cases. 2015 Jan 16;3(1):42-51
pubmed: 25610849
J Thorac Oncol. 2007 May;2(5):423-9
pubmed: 17473658
N Engl J Med. 2006 Jun 15;354(24):2619-21
pubmed: 16775247
Mol Cell. 2003 Feb;11(2):507-17
pubmed: 12620237
Eur J Cancer. 2019 Mar;109:28-35
pubmed: 30685684
JTO Clin Res Rep. 2020 Aug 07;1(4):100081
pubmed: 34589960
Cancers (Basel). 2022 Apr 30;14(9):
pubmed: 35565387
J Clin Oncol. 2022 Mar 1;40(7):719-728
pubmed: 35073148
Ann Oncol. 2015 Jul;26(7):1421-7
pubmed: 25899785
Cancer. 2019 Dec 15;125(24):4380-4387
pubmed: 31469421
Science. 2004 Jun 4;304(5676):1497-500
pubmed: 15118125
EMBO J. 1997 Apr 1;16(7):1647-55
pubmed: 9130710
Clin Cancer Res. 2022 Feb 1;28(3):461-467
pubmed: 34753778
J Thorac Oncol. 2018 Dec;13(12):1897-1905
pubmed: 30096481
J Thorac Oncol. 2017 Mar;12(3):446-457
pubmed: 27903463
ESMO Open. 2022 Feb;7(1):100395
pubmed: 35149428
Clin Cancer Res. 2019 Apr 1;25(7):2033-2041
pubmed: 30442682
Genes Chromosomes Cancer. 2022 May;61(5):244-260
pubmed: 34997651
BMC Cancer. 2018 Mar 27;18(1):326
pubmed: 29587667
Transl Lung Cancer Res. 2021 Feb;10(2):753-765
pubmed: 33718019
Pharmacol Ther. 2019 Jul;199:188-196
pubmed: 30951733
J Biol Chem. 1980 Sep 25;255(18):8363-5
pubmed: 6157683
Eur J Cancer. 2022 Aug;171:114-123
pubmed: 35716537
Br J Cancer. 2002 May 6;86(9):1449-56
pubmed: 11986780
N Engl J Med. 2013 Jun 20;368(25):2385-94
pubmed: 23724913
Front Oncol. 2020 May 12;10:729
pubmed: 32477948
Transl Lung Cancer Res. 2014 Apr;3(2):84-8
pubmed: 25806285
Clin Lung Cancer. 2018 Sep;19(5):e775-e781
pubmed: 30149884
J Clin Oncol. 2018 Aug 20;36(24):2532-2537
pubmed: 29989854
Nature. 2018 Feb 8;554(7691):189-194
pubmed: 29420467
Lancet Oncol. 2016 Jul;17(7):984-993
pubmed: 27283860
J Thorac Oncol. 2018 Feb;13(2):273-279
pubmed: 29313813
Nature. 2013 Oct 17;502(7471):333-339
pubmed: 24132290
Lung Cancer. 2001 Aug-Sep;33(2-3):115-23
pubmed: 11551406
N Engl J Med. 2005 Oct 20;353(16):1659-72
pubmed: 16236737
J Clin Oncol. 2020 Aug 20;38(24):2753-2761
pubmed: 32614698
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153
N Engl J Med. 2004 May 20;350(21):2129-39
pubmed: 15118073
Thorac Cancer. 2021 Jan;12(2):218-226
pubmed: 33210451
Cancers (Basel). 2022 Apr 12;14(8):
pubmed: 35454838
N Engl J Med. 2022 Jan 20;386(3):286-289
pubmed: 35045232
J Thorac Oncol. 2008 May;3(5):477-82
pubmed: 18448999
Ann Oncol. 2016 Feb;27(2):281-6
pubmed: 26598547
Lung Cancer. 2021 Oct;160:50-58
pubmed: 34403912
J Thorac Oncol. 2021 Nov;16(11):1952-1958
pubmed: 34245914
Oncotarget. 2017 Nov 30;8(69):114371-114392
pubmed: 29371993
Lung Cancer. 2015 Apr;88(1):63-9
pubmed: 25682316
N Engl J Med. 2005 Oct 20;353(16):1673-84
pubmed: 16236738
J Thorac Oncol. 2014 Dec;9(12):1750-62
pubmed: 25247338

Auteurs

Christophe Bontoux (C)

Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, Pasteur Hospital, Centre Hospitalier Universitaire de Nice, Biobank BB-0033-00025, 06000 Nice, France.
IRCAN Team 4, Inserm U1081/CNRS 7284, Centre de Lutte Contre le Cancer Antoine Lacassagne, 06000 Nice, France.
FHU OncoAge, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.

Jonathan Benzaquen (J)

IRCAN Team 4, Inserm U1081/CNRS 7284, Centre de Lutte Contre le Cancer Antoine Lacassagne, 06000 Nice, France.
FHU OncoAge, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.
Department of Pneumology, Pasteur Hospital, University Côte d'Azur, 30 Avenue de la Voie Romaine, 06000 Nice, France.

Véronique Hofman (V)

Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, Pasteur Hospital, Centre Hospitalier Universitaire de Nice, Biobank BB-0033-00025, 06000 Nice, France.
IRCAN Team 4, Inserm U1081/CNRS 7284, Centre de Lutte Contre le Cancer Antoine Lacassagne, 06000 Nice, France.
FHU OncoAge, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.

Simon Heeke (S)

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

Paul Hannetel (P)

Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, Pasteur Hospital, Centre Hospitalier Universitaire de Nice, Biobank BB-0033-00025, 06000 Nice, France.

Pierre Capela-Brosseau-Laborde (P)

Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, Pasteur Hospital, Centre Hospitalier Universitaire de Nice, Biobank BB-0033-00025, 06000 Nice, France.

Charles-Hugo Marquette (CH)

IRCAN Team 4, Inserm U1081/CNRS 7284, Centre de Lutte Contre le Cancer Antoine Lacassagne, 06000 Nice, France.
FHU OncoAge, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.
Department of Pneumology, Pasteur Hospital, University Côte d'Azur, 30 Avenue de la Voie Romaine, 06000 Nice, France.

Marius Ilié (M)

Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, Pasteur Hospital, Centre Hospitalier Universitaire de Nice, Biobank BB-0033-00025, 06000 Nice, France.
IRCAN Team 4, Inserm U1081/CNRS 7284, Centre de Lutte Contre le Cancer Antoine Lacassagne, 06000 Nice, France.
FHU OncoAge, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.

Paul Hofman (P)

Laboratory of Clinical and Experimental Pathology, Université Côte d'Azur, Pasteur Hospital, Centre Hospitalier Universitaire de Nice, Biobank BB-0033-00025, 06000 Nice, France.
IRCAN Team 4, Inserm U1081/CNRS 7284, Centre de Lutte Contre le Cancer Antoine Lacassagne, 06000 Nice, France.
FHU OncoAge, Centre Hospitalier Universitaire de Nice, 06000 Nice, France.

Classifications MeSH